| Massively parallel digital transcriptional profiling of single cells GXY Zheng, JM Terry, P Belgrader, P Ryvkin, ZW Bent, R Wilson, ... Nature communications 8 (1), 14049, 2017 | 6102 | 2017 |
| Five-year follow-up of patients receiving imatinib for chronic myeloid leukemia BJ Druker, F Guilhot, SG O'Brien, I Gathmann, H Kantarjian, N Gattermann, ... New England Journal of Medicine 355 (23), 2408-2417, 2006 | 4467 | 2006 |
| European LeukemiaNet recommendations for the management of chronic myeloid leukemia: 2013 M Baccarani, MW Deininger, G Rosti, A Hochhaus, S Soverini, ... Blood, The Journal of the American Society of Hematology 122 (6), 872-884, 2013 | 2659 | 2013 |
| Chronic myeloid leukemia: an update of concepts and management recommendations of European LeukemiaNet M Baccarani, J Cortes, F Pane, D Niederwieser, G Saglio, J Apperley, ... Journal of clinical oncology 27 (35), 6041-6051, 2009 | 1895 | 2009 |
| Hematopoietic cell transplantation in older patients with hematologic malignancies: replacing high-dose cytotoxic therapy with graft-versus-tumor effects PA McSweeney, D Niederwieser, JA Shizuru, BM Sandmaier, AJ Molina, ... Blood, The Journal of the American Society of Hematology 97 (11), 3390-3400, 2001 | 1686 | 2001 |
| International Consensus Classification of Myeloid Neoplasms and Acute Leukemias: integrating morphologic, clinical, and genomic data DA Arber, A Orazi, RP Hasserjian, MJ Borowitz, KR Calvo, HM Kvasnicka, ... Blood, The Journal of the American Society of Hematology 140 (11), 1200-1228, 2022 | 1676 | 2022 |
| Frequency of major molecular responses to imatinib or interferon alfa plus cytarabine in newly diagnosed chronic myeloid leukemia TP Hughes, J Kaeda, S Branford, Z Rudzki, A Hochhaus, ML Hensley, ... New England Journal of Medicine 349 (15), 1423-1432, 2003 | 1618 | 2003 |
| Monitoring CML patients responding to treatment with tyrosine kinase inhibitors: review and recommendations for harmonizing current methodology for detecting BCR-ABL … T Hughes, M Deininger, A Hochhaus, S Branford, J Radich, J Kaeda, ... Blood 108 (1), 28-37, 2006 | 1548 | 2006 |
| The case for early detection R Etzioni, N Urban, S Ramsey, M McIntosh, S Schwartz, B Reid, J Radich, ... Nature reviews cancer 3 (4), 243-252, 2003 | 1526 | 2003 |
| European LeukemiaNet 2020 recommendations for treating chronic myeloid leukemia A Hochhaus, M Baccarani, RT Silver, C Schiffer, JF Apperley, F Cervantes, ... Leukemia 34 (4), 966-984, 2020 | 1416 | 2020 |
| Long-term outcomes of imatinib treatment for chronic myeloid leukemia A Hochhaus, RA Larson, F Guilhot, JP Radich, S Branford, TP Hughes, ... New England Journal of Medicine 376 (10), 917-927, 2017 | 1362 | 2017 |
| The role of FLT3 in haematopoietic malignancies DL Stirewalt, JP Radich Nature Reviews Cancer 3 (9), 650-665, 2003 | 1194 | 2003 |
| Six-year follow-up of patients receiving imatinib for the first-line treatment of chronic myeloid leukemia A Hochhaus, SG O'brien, F Guilhot, BJ Druker, S Branford, L Foroni, ... Leukemia 23 (6), 1054-1061, 2009 | 1160 | 2009 |
| Lin28 promotes transformation and is associated with advanced human malignancies SR Viswanathan, JT Powers, W Einhorn, Y Hoshida, TL Ng, S Toffanin, ... Nature genetics 41 (7), 843-848, 2009 | 965 | 2009 |
| International randomized study of interferon vs STI571 (IRIS) 8-year follow up: sustained survival and low risk for progression or events in patients with newly diagnosed … M Deininger, SG O'Brien, F Guilhot, JM Goldman, A Hochhaus, ... Blood 114 (22), 1126, 2009 | 961 | 2009 |
| Bone marrow transplants from unrelated donors for patients with chronic myeloid leukemia JA Hansen, TA Gooley, PJ Martin, F Appelbaum, TR Chauncey, RA Clift, ... New England Journal of Medicine 338 (14), 962-968, 1998 | 761 | 1998 |
| Gene expression changes associated with progression and response in chronic myeloid leukemia JP Radich, H Dai, M Mao, V Oehler, J Schelter, B Druker, C Sawyers, ... Proceedings of the National Academy of Sciences 103 (8), 2794-2799, 2006 | 720 | 2006 |
| Prevalence and prognostic significance of Flt3 internal tandem duplication in pediatric acute myeloid leukemia S Meshinchi, WG Woods, DL Stirewalt, DA Sweetser, JD Buckley, TK Tjoa, ... Blood, The Journal of the American Society of Hematology 97 (1), 89-94, 2001 | 670 | 2001 |
| Long-term prognostic significance of early molecular response to imatinib in newly diagnosed chronic myeloid leukemia: an analysis from the International Randomized Study of … TP Hughes, A Hochhaus, S Branford, MC Müller, JS Kaeda, L Foroni, ... Blood, The Journal of the American Society of Hematology 116 (19), 3758-3765, 2010 | 633 | 2010 |
| FLT3, RAS, and TP53 mutations in elderly patients with acute myeloid leukemia DL Stirewalt, KJ Kopecky, S Meshinchi, FR Appelbaum, ML Slovak, ... Blood, The Journal of the American Society of Hematology 97 (11), 3589-3595, 2001 | 559 | 2001 |
